Keros Therapeutics Inc (KROS)
17.98
-1.44
(-7.42%)
USD |
NASDAQ |
Dec 17, 16:00
17.87
-0.11
(-0.61%)
After-Hours: 17:39
Keros Therapeutics Shareholders Equity (Quarterly): 532.84M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Aptevo Therapeutics Inc | 4.42M |
| Corcept Therapeutics Inc | 638.84M |
| Regeneron Pharmaceuticals Inc | 29.33B |
| Scholar Rock Holding Corp | 79.20M |
| Trevi Therapeutics Inc | 58.97M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 579.27M |
| Total Liabilities (Quarterly) | 46.44M |
| Current Ratio | 19.03 |